127799-53-5

Basic information

• Product Name: 1-(benzylo×y)carbonyl-2-(t-butylo×y)carbonyl-1-Methylhydrazine
• Synonyms: 1-(benzylo×y)carbonyl-2-(t-butylo×y)carbonyl-1-Methylhydrazine;1-Benzyl 2-tert-butyl 1-Methylhydrazine-1,2-dicarboxylate
• CAS NO: 127799-53-5
• Molecular Formula: C₁₄H₂₀N₂O₄
• Molecular Weight: 280.3196
• Mol File: 127799-53-5.mol
• Article Data: 11

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 1-(benzylo×y)carbonyl-2-(t-butylo×y)carbonyl-1-Methylhydrazine(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(benzylo×y)carbonyl-2-(t-butylo×y)carbonyl-1-Methylhydrazine(127799-53-5)
• EPA Substance Registry System: 1-(benzylo×y)carbonyl-2-(t-butylo×y)carbonyl-1-Methylhydrazine(127799-53-5)

Safety Data

• Hazardous Substances Data: 127799-53-5(Hazardous Substances Data)

Usage

General Description

1-(benzyloxy)carbonyl-2-(t-butyloxy)carbonyl-1-Methylhydrazine is a chemical compound that consists of a benzyl group, a t-butyl group, and a carbonyl group attached to a methylhydrazine molecule. 1-(benzylo×y)carbonyl-2-(t-butylo×y)carbonyl-1-Methylhydrazine is used in organic synthesis as a building block for various pharmaceuticals and agrochemicals. It has a range of applications in the production of potential drug candidates, as well as in the development of new materials and chemical reactions. The presence of the benzyl and t-butyl groups in the compound can influence its reactivity and stability, making it an important intermediate in organic chemistry. Researchers continue to explore the potential uses and applications of this compound in the field of chemical synthesis and drug discovery.

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 37519-04-3 1-(benzyloxy)carbonyl-1-methylhydrazine 
• 200813-54-3 2-benzyloxycarbonyl-1-tert-butoxycarbonyl-2-methyl-1-(4-methylphenylsulfonyl)hydrazine 
• 185456-32-0 1-benzyl-1,2,2-tris(tert-butoxycarbonyl)hydrazine 
• 426840-24-6 N^α-(benzyloxycarbonyl)-N^β,N^β-bis(tert-butyloxycarbonyl)-N^α-methylhydrazine 
• 5331-43-1 N-benzyloxycarbonyl-hydrazine 
• 287728-91-0 N-benzyloxycarbonylaminophthalimide 
• 287729-06-0 N-methyl-N-benzyloxycarbonylaminophthalimide 
• 287729-00-4 N-benzyl-N-tert-butyloxycarbonylaminophthalimide 
• 200813-52-1 benzyl 2-tosylhydrazine-1-carboxylate 
• 200813-53-2 1-tert-butoxycarbonyl-1-tosyl-2-benzyloxycarbonylhydrazine 

Downstream Products

• 127799-54-6 2-Methylhydrazinecarboxylic acid,1,1-dimethylethyl ester 
• 220079-14-1 1-(benzyloxycarbonyl)-2-(tert-butoxycarbonyl)-2-ethyl-1-methylhydrazine 
• 220079-16-3 N'-Ethyl-N-methyl-hydrazinecarboxylic acid benzyl ester 
• 220079-20-9 N'-Ethyl-N'-(4-fluoro-benzoyl)-N-methyl-hydrazinecarboxylic acid benzyl ester 
• 220079-68-5 N-Ethyl-N'-methyl-N'-(toluene-4-sulfonylaminocarbonyl)-hydrazinecarboxylic acid tert-butyl ester 
• 220079-41-4 N'-Ethyl-N-methyl-N'-(toluene-4-sulfonylaminocarbonyl)-hydrazinecarboxylic acid benzyl ester 
• 220079-71-0 N'-[Benzyl-(toluene-4-sulfonyl)-aminocarbonyl]-N-ethyl-N'-methyl-hydrazinecarboxylic acid tert-butyl ester 
• 220079-44-7 1-(benzyloxycarbonyl)-2-ethyl-1-methyl-2-[(trideuteromethyl)tosylcarbamoyl]hydrazine 
• 151988-40-8 (S)-2-(N'-tert-Butoxycarbonyl-N-methyl-hydrazinocarbonyl)-pyrrolidine-1-carboxylic acid benzyl ester 

Relevant articles and documents

FACTOR XIA-INHIBITING PYRIDOBENZAZEPINE AND PYRIDOBENZAZOCINE DERIVATIVES

The invention relates to substituted pyridobenzazepine and pyridobenzazocine derivatives and to processes for preparation thereof, and also to the use thereof for production of medicaments for treatment and/or prophylaxis of diseases, especially of cardiovascular disorders, preferably thrombotic or thromboembolic disorders, and oedemas, and also ophthalmic disorders.

SUBSTITUTED OXOPYRIDINE DERIVATIVES AND USE THEREOF IN THE TREATMENT OF CARDIOVASCULAR DISORDERS

The invention relates to substituted oxopyridine derivatives and to processes for their preparation, and also to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular cardiovascular disorders, preferably thrombotic or thromboembolic disorders, and oedemas, and also ophthalmic disorders.

Very efficient one-pot conversion of N-aminophthalimide derivatives into the corresponding N-amino-di-tert-butyl imidodicarbonates

The phthaloyl group can be efficiently converted in very mild conditions into bis-tert-butyloxycarbonyl group using MeNH2, then Boc2O/DMAP, in a one-flask protocol.